2019
- Medicines Australia submission to the TGA consultation on modification of an existing provisional registration Friday, 29 January 2021
- Medicines Australia submission to the TGA consultation on modification of an existing provisional registration Friday, 29 January 2021
- Medicines Australia’s submission to the Consultations on PBS Process Improvements Friday, 29 January 2021
- Medicines Australia response to the Draft Cost Recovery Impact Statement (CRIS) for Listing Medicines on the PBS and Designated Vaccines on the NIP 2019-20 Friday, 29 January 2021
- Medicines Australia response to the Australian Government’s Vocational Education and Training (VET) review Wednesday, 25 September 2019
- Therapeutic Goods Order 78 (TGO78) – Standard for tablets and capsules Wednesday, 25 September 2019
- Medicines Australia’s submission to the TGA Consultation: Good Clinical Practice Inspections Program Wednesday, 25 September 2019
- Medicines Australia’s submission to the Australian Commission on Safety and Quality in Health Care’s Clinical Trials Governance Framework Consultation Wednesday, 25 September 2019
- Medicines Australia’s submission to the Discussion Paper: Co-designing and publishing a Digital Medicines Program Blueprint Wednesday, 25 September 2019
- Medicines Australia’s submission to the TGA Consultation on the reforms to the generic medicine market authorisation process Wednesday, 25 September 2019
- Medicines Australia’s submission to the consultation on whether the TGA should publish that a prescription medicine is under evaluation Wednesday, 25 September 2019
- Medicines Australia’s submission to the Productivity Commission – The Social and Economic Benefits of Improving Mental Health Wednesday, 25 September 2019
- Medicines Australia submission to the New Zealand Ministry of Health Therapeutic Products Regulatory Scheme – draft Therapeutic Products Bill Wednesday, 25 September 2019
- Medicines Australia’s submission to the Department of Health’s Review of the Quality Use of Medicines (QUM) Program Delivery by NPS MedicineWise Wednesday, 25 September 2019
- Medicines Australia’s submission on the Public consultation on Positive Recommendation Pathways process and guidance Wednesday, 25 September 2019
- Medicines Australia’s submission on the consultation paper specific to the introduction of a consumer-friendly Medicines Status Website (MSW) Wednesday, 25 September 2019
- Medicines Australia submission on the Department of Health Australia’s Antimicrobial Resistance Strategy 2020 and beyond Wednesday, 25 September 2019
- Medicines Australia submission to the Intellectual Property Laws Amendment (Productivity Commission Response Part 2 and Other Measures) Bill 2019 Wednesday, 25 September 2019
- Medicines Australia submission on the Public consultation on standardised redaction of Public Summary Documents Wednesday, 25 September 2019
- Medicines Australia submission to the TGA targeted consultation on generic medicines reforms Wednesday, 25 September 2019
- Medicines Australia submission to TGA consultation on increased online access to ingredient information Wednesday, 25 September 2019
- Medicines Australia submission to the Australian Government consultation on Data Sharing and Release – Legislative Reforms Wednesday, 25 September 2019
- Medicines Australia submission to the proposed clarification of the regulatory requirements for medical device systems and procedure packs Wednesday, 25 September 2019
- Medicines Australia submission to the proposed changes to the medical device Essential Principles for safety and performance Wednesday, 25 September 2019
- Medicines Australia response to the Therapeutic Goods Administration (TGA) consultations relevant to Medical Devices Sunday, 25 August 2019
- Medicines Australia submission on the Extension of the Consultations for Sustainability Impact Assessment – Negotiations on FTA between the EU and Australia Sunday, 25 August 2019
- Medicines Australia Federal Budget Submission 2019-2020 2 pager Monday, 29 July 2019
- Medicines Australia response on the Therapeutic Goods Administration (TGA) consultation paper ‘Proposal for the regulation of IVD companion diagnostics’ Thursday, 25 July 2019
- Proposed criteria for Appendix M of the Poisons Standard to support rescheduling of substances from Schedule 4 (Prescription only) to Schedule 3 (Pharmacist only) Tuesday, 25 June 2019
- Medicines Australia submission to the National Action Plan for Blood Cancer Tuesday, 22 January 2019
- Medicines Australia response – Consultation on the Community Service Obligation (CSO) Funding Pool Obligations (2019) Tuesday, 25 September 2018